Articles

All (77)
SCI-E, SSCI, AHCI (53)
SCI-E, SSCI, AHCI, ESCI (53)
Scopus (56)
TRDizin (10)
Other Publications (15)

2010

2010

16. Infected Kaposi's Sarcoma

Balkan I., Ozaras R., Mert A.

INTERNAL MEDICINE , vol.49, no.23, pp.2649, 2010 (SCI-Expanded) identifier identifier identifier

2001

2001

59. Ardışık antibiyotik tedavisi

MERT A., ÖZARAS R.

İnfeksiyon Hastalıkları Serisi , vol.3, pp.26-33, 2001 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences

2018

2018

1. The Determination of Tenofovir Level in Breast Milk of Nursing Mothers Under Tenofovir Therapy

Erturk U. S., Mete B., Ozaras R., Saltoglu N., Balkan I. I., Mert A., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Costa Rica, 9 - 13 November 2018, vol.68, (Summary Text) identifier

2011

2011

5. Correlation with minimal inhibitory concentration values and mortality in Staphylococcus aureus bacteremic patients

Kara O., Balkan İ. İ., METE B., YEMİŞEN M., AYGÜN G., SALTOĞLU N., et al.

The 4th EURASIA Congress of Infectious Diseases, Bosna, Bosnia And Herzegovina, 1 - 05 June 2011, pp.138, (Summary Text)

2011

2011

6. Molecular characterisation and epidemiology of a carbapenem-resistant Enterobacteriaceae outbreak in a tertiary care centre.

Yilmaz M., Aydin S., METE B., Nazik H., Ongen B., ÖZARAS R., et al.

21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy, Milano, Italy, 7 - 10 May 2011, vol.1, pp.2356, (Summary Text)

2011

2011

7. Cerrahpaşa Tıp fakültesi hastanesinde acinetobacter bakteremilerinde son 2 yıldaki antimikrobiyallere direncin değerlendirilmesi

Vatan A., SALTOĞLU N., METE B., Hondur N., ÖZARAS R., MERT A., et al.

15. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi, Antalya, Turkey, 23 - 27 March 2011, pp.352-353, (Summary Text)

2010

2010

8. DEMONSTRATION OF HCV SPECIFIC LYMPHOCYTE RESPONSE IN ANTI-HCV POSITIVE, HCV-RNA NEGATIVE INDIVIDUALS USING PEPTIDE ARRAYS

Sili U., Aydin S., Hondur N., Saltoglu N., Ozturk R., Tabak F., et al.

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 29 October - 02 November 2010, vol.52, (Summary Text) identifier

2010

2010

9. Seronegatif Lyme Hastalığı: Dokuda PCR ile Tanısı Doğrulanmış İki Olgu Sunumu

Arslan F., Ergin S., METE B., ÖZARAS R., MERT A., MİDİLLİ K., et al.

3. EKMUD Kongresi, Ankara, Turkey, 12 - 16 May 2010, vol.1, pp.334, (Full Text)

2009

2009

11. Dört Olgu Nedeniyle Trikosporonoz

Vanli E., METE B., Ar C., ÖZARAS R., Başlar Z., Ferhanoglu B., et al.

24. ANKEM Kongresi, Muğla, Turkey, 29 March - 03 April 2009, vol.23, pp.75

2009

2009

12. The Correlation of Hepatic Apoptotic Markers and Histology and Their Predictive Role in Estimating the Response to Therapy in Chronic Hepatitis C

ÖZARAS R., TABAK Ö. F., Tahan V., ÖZBAY G., Çelikel Ç. A., MİDİLLİ K., et al.

The 19th Conference of the Asian Pacific Association for the Study of the Liver, Hongkong, Hong Kong, 13 - 16 February 2009, vol.3, pp.187, (Full Text) Sustainable Development

2008

2008

13. HEPATIC APOPTOTIC MARKERS ARE ASSOCIATED WITH HISTOLOGY BUT MAY NOT PREDICT THE RESPONSE TO THERAPY IN CHRONIC HEPATITIS C

Ozaras R., Tahan V., Ozbay G., ÇELİKEL Ç., Midilli K., Kaygusuz A., et al.

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 31 October - 04 November 2008, vol.48, (Summary Text) Sustainable Development identifier

2008

2008

14. Warning! Oxacillinase-mediated carbapenem resistance spreading in Enterobacteriaceae

Yilmaz M., Aybar Y., MİDİLLİ K., ÖZARAS R., MERT A., TABAK Ö. F., et al.

8th European Congress of Clinical Microbiology and Infectious Diseases., Barselona, Spain, 19 - 22 April 2008, vol.1, pp.1517, (Full Text)

2008

2008

15. Recurrent prosthetic valve endocarditis caused by Staphylococcus warnerii

Arslan F., Karaali R., SALTOĞLU N., METE B., Velet S., ÖZARAS R., et al.

The Second International Congress of Central Asia Infectious Diseases, Almaata, Kazakhstan, 27 - 30 March 2008, vol.1, pp.1, (Full Text)

2008

2008

16. Febril nötropenik hastalarda etken dağılımı: Cerrahpaşa Deneyimi.

METE B., TABAK Ö. F., Ar C., Demirel A. E., ÖZARAS R., ÖNGÖREN AYDIN Ş., et al.

8. Febril Nötropeni Sempozyumu, Ankara, Turkey, 21 - 24 February 2008, vol.1, pp.1, (Full Text) Sustainable Development

2007

2007

18. Tüberküloza Bağlı Protez Eklem Enfeksiyonu Olgusu

YEMİŞEN M., METE B., Aydin S., ÖZARAS R., TABAK Ö. F., MERT A., et al.

ANKEM Kongresi, Antalya, Turkey, 29 April - 03 May 2007, vol.1, pp.22

2007

2007

19. Piperasilin-tazobaktam Tedavisi Sırasında Gelişen Akut Böbrek Yetmezliği

METE B., YEMİŞEN M., Terzi Demirsoy E., ÖZARAS R., TABAK Ö. F., MERT A., et al.

ANKEM Kongresi, Antalya, Turkey, 29 April - 03 May 2007, vol.1, pp.47, (Full Text)

2007

2007

21. Rash and fever in adults: the aetiology and clinical features

TABAK Ö. F., Murtezaoglu A., ÖZARAS R., METE B., Tabak O., MERT A., et al.

17th European Congress of Clinical Microbiology and Infectious Diseases/25th International Congress of Chemotherapy, Munih, Germany, 31 March - 03 April 2007, vol.29, pp.309, (Full Text)

2007

2007

23. Is HCV genotyping cost-effective in Turkey?

Tahan V., ÖZARAS R., Uraz S., KARACA Ç., Eren F., Danalioglu A., et al.

17th APASL Conference, Kyoto, Japan, 27 - 30 March 2007, vol.1, pp.139, (Full Text)

2007

2007

25. Correlation of quantitative assay of HBsAg and HBV-DNA levels during chronic HBV treatment.

ÖZARAS R., TABAK Ö. F., Kaygusuz A., Tahan V., ÖZTÜRK R., MERT A., et al.

17th APASL Conference, Kyoto, Japan, 27 - 30 March 2007, vol.1, no.7, pp.7, (Full Text)

2006

2006

26. HBV Tedavisi Sırasında Apoptotik Hücre Ölümünün Biyokimyasal Ve Viral Kinetiklerle İlişkisi.

ÖZARAS R., TABAK Ö. F., Kaygusuz A., Tahan V., ÖZTÜRK R., MERT A., et al.

23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.1, pp.1, (Full Text)

2005

2005

28. Yanlış pozitif kan kültürü oranları ve laboratuvar maliyeti

Kurt C., Yilmaz M., METE B., YEMİŞEN M., Demirel A. E., Vanli E., et al.

12. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi KLİMİK, Antalya, Turkey, 16 - 20 November 2005, vol.18, pp.213, (Full Text)

2005

2005

29. Mycobacterium tuberculosis bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection

Seyhan E., MERT A., Altın S., Çetinkaya E., Epozturk K., ÖZARAS R.

European Respiratory Society Annual Congress, Kopenhag, Denmark, 17 - 21 September 2005, vol.1, pp.1, (Full Text) Sustainable Development

2005

2005

30. Febril nötropenik hasta izleminde CRP’nin yeri.

ÖZARAS R., Yilmaz M., Ar C., ÖNGÖREN AYDIN Ş., Başlar Z., SOYSAL T., et al.

20. ANKEM Klinik ve Tıp Bilimleri Kongresi, Antalya, Turkey, 22 - 26 May 2005, vol.19, pp.15

2005

2005

31. Katalaz Negatif Staphylococcus aureus’ un Etken Olduğu İki Olgu Sunumu.

Yilmaz M., Çelik Y., METE B., AYGÜN G., Utku T., ÖZARAS R., et al.

20. ANKEM Klinik ve Tıp Bilimleri Kongresi, Antalya, Turkey, 22 - 26 May 2005, vol.19, pp.59

2005

2005

35. The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.

Canbakan B., ŞENTÜRK H., TABAK Ö. F., Akdoğan M., ÖZARAS R., Tahan V., et al.

Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Chicago, United States Of America, 14 - 19 May 2005, vol.128, no.4, pp.771-772 Sustainable Development

2005

2005

36. Febril nötropenik hastalarda vankomisine dirençli enterokok: 3 olgu bildirimi

METE B., Demirel A. E., YEMİŞEN M., Aybar Y., Çelik Y., ÖZARAS R., et al.

6. Febril Nötropeni Sempozyumu, Ankara, Turkey, 24 - 27 February 2005, vol.1, pp.190, (Full Text)

2005

2005

37. Febril Nötropenik Hastalarda Ampirik Antibiyoterapi, Etkenler ve Duyarlılıkları - Cerrahpaşa Deneyimi.

Yilmaz M., Ar C., ÖNGÖREN AYDIN Ş., ÖZARAS R., Başlar Z., SOYSAL T., et al.

6. Febril Nötropeni Simpozyumu, Ankara, Turkey, 24 - 27 February 2005, vol.210, pp.81, (Full Text)

2004

2004

38. Prevalence and significance of hepatic granulomas in chronic hepatitis B

Tahan V., ÖZARAS R., Lacevic N., Özden E., Özdoğan O. C., MERT A., et al.

Asia Pacific Association for the Study of the Liver, 14th Biennal Conference,, Yeni Delhi, India, 11 - 15 December 2004, vol.19, pp.741, (Full Text) Sustainable Development

2004

2004

39. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats.

Tahan V., ÖZARAS R., Canbakan B., UZUN H., AYDIN S., Yildirim B., et al.

21. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 31 August - 05 September 2004, vol.1, pp.1, (Full Text)

2004

2004

40. In Vitro Susceptibility of Fusidic Acid in Staphylococcal strains during 3 years

Hakko E., Murtezaoglu A., METE B., ÖZARAS R., MERT A., ÖZTÜRK R., et al.

14th European Congress of Clinical Microbiology and Infectious Diseases., Prag, Czech Republic, 1 - 04 May 2004, vol.10, pp.1944, (Full Text)

2003

2003

41. Pulmonary emboli may present solely with fever in the elderly.

ÖZARAS R., YEMİŞEN M., Subaşı B., Yilmaz M., MERT A., TABAK Ö. F., et al.

17th Asia Pacific Congress on Diseases of the Chest, İstanbul, Turkey, 29 August - 01 September 2003, vol.1, pp.59

2003

2003

42. Ziehl-Neelsen staining and PCR study in paraffin-embedded slides of tuberculous granulomas.

MERT A., ÖZARAS R., BİLİR M., TABAK Ö. F., Aki H., ÖZTÜRK R.

13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.637

2003

2003

43. Acute hepatitis due to brucellosis.

ÖZARAS R., Çelik A. D., MERT A., TABAK Ö. F., ÖZTÜRK R.

13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.454 Sustainable Development

2003

2003

44. Diagnostic laparotomy in the diagnosis of fever of unknown origin.

ÖZARAS R., Çelik A. D., Zengin K., MERT A., ÖZTÜRK R., TABAK Ö. F.

13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.1069

2003

2003

45. Fever of unknown origin caused by CMV infection in a patient with Behcet syndrome

MERT A., ÖZARAS R., Sipahi S., Ayata E., TABAK Ö. F., ÖZTÜRK R.

13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.883, (Full Text)

2003

2003

46. The prevalence of hepatic granulomas in chronic hepatitis C.

ÖZARAS R., Tahan V., MERT A., TABAK Ö. F., Avşar E., ÖZBAY G., et al.

13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.1178, (Full Text) Sustainable Development

2003

2003

47. Fever of unknown origin: a review of 51 patients.

MERT A., ÖZARAS R., TABAK Ö. F., BİLİR M., Yilmaz M., ÖZTÜRK R.

13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.1650, (Full Text)

2003

2003

48. Intrathoracic lymphadenopathy in adults: a review of 30 cases.

MERT A., ÖZARAS R., BİLİR M., TABAK Ö. F., ÖZTÜRK R.

13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.1068, (Full Text)

2003

2003

49. Severe eosinophilia during the course of toxic shock syndrome.

ÖZARAS R., MERT A., TABAK Ö. F., BİLİR M., ÖZTÜRK R.

13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.681, (Full Text)

2003

2003

50. Levofloksasinin Yol Açtığı Deliryum

Hakko E., METE B., ÖZARAS R., MERT A., TABAK Ö. F., ÖZTÜRK R.

11. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları (KLİMİK) Kongresi, İstanbul, Turkey, 30 - 03 April 2003, vol.1, pp.342, (Full Text)

2003

2003

51. Bruselloza Bağlı Torakal ve Lomber Vertebra Tutulumlu Spondilodiskit

Çelik A. D., ÖZARAS R., Kumbasar H., MERT A., TABAK Ö. F., ÖZTÜRK R.

11. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları (KLİMİK) Kongresi, İstanbul, Turkey, 30 March - 03 April 2003, vol.1, pp.310, (Full Text)

2003

2003

52. Methylobacterium mesophilicum’a Bağlı Meningoensefalit Olgusu

ÖZARAS R., METE B., Kaya G., Şen S., MERT A., Selçuk H., et al.

11. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları (KLİMİK) Kongresi, İstanbul, Turkey, 30 March - 03 April 2003, vol.1, pp.286, (Full Text)

2003

2003

53. Nedeni Bilinmeyen Ateşe Yol Açan Kranyal Diabetes Insipidus

Çelik A. D., ÖZARAS R., MERT A., ÖZTÜRK R., TABAK Ö. F.

11. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları (KLİMİK) Kongresi, İstanbul, Turkey, 30 March - 03 April 2003, vol.1, pp.511, (Full Text) Sustainable Development

2003

2003

54. Enterovirüs Menenjiti: İki Olgu Sunumu

ÖZARAS R., Çelik A. D., Ergin S., MERT A., TABAK Ö. F., MİDİLLİ K., et al.

11. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları (KLİMİK) Kongresi, İstanbul, Turkey, 30 March - 03 April 2003, vol.1, pp.290, (Full Text)

2002

2002

55. Hepatit C Virüsünde Olası Bulaşma Kaynakları

Yildirim B., TABAK Ö. F., ÖZARAS R., Aytekin H., Barut G., MERT A., et al.

6. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 31 October - 02 November 2002, vol.1, pp.35 Sustainable Development

2002

2002

56. HCV Enfeksiyonunda Aile İçi Geçiş

Yildirim B., TABAK Ö. F., ÖZARAS R., Aytekin H., ŞENTÜRK H., MERT A.

6. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 31 October - 02 November 2002, vol.1, pp.34

2002

2002

58. Yoğun bakım ünitesinde izole edilen non-fermentatif kökenlerin antibiyotik duyarlılıkları

METE B., Murtezaoglu A., Hakko E., AYGÜN G., ÖZARAS R., TABAK Ö. F., et al.

XXX. Türk Mikrobiyoloji Kongresi, Antalya, Turkey, 15 September - 05 October 2002, vol.1, pp.344, (Full Text)

2002

2002

59. Antiphospholipid syndrome as a cause of fever of unknown origin.

ÖZARAS R., METE B., ÖZTÜRK R., MERT A., TABAK Ö. F., ŞENTÜRK H., et al.

12th European Congress of Clinical Microbiology and Infectious Diseases., Milano, Italy, 21 - 24 April 2002, vol.8, pp.1580

2002

2002

60. Ornidazole-induced liver damage.

TABAK Ö. F., ÖZARAS R., Erzin Y. Z., Çelik A. D., MERT A., ÖZTÜRK R., et al.

12th European Congress of Clinical Microbiology and Infectious Diseases., Milano, Italy, 21 - 24 April 2002, vol.8, pp.1356, (Full Text)

2001

2001

61. Profile of microorganisms isolated from febrile neutropenic patients.

Ferhanoğlu B., Acicbe Ö., ÖNGÖREN AYDIN Ş., TABAK Ö. F., BAŞLAR Z., ÖZTÜRK R., et al.

The American Society of Hematology 43rd Annual Meeting, Florida, United States Of America, 7 - 11 December 2001, vol.98, pp.26, (Summary Text)

2001

2001

62. Kronik hepatit polikliniği: 9 yıllık Cerrahpaşa deneyimi

TABAK Ö. F., ŞENTÜRK H., MERT A., Tahan V., ÖZARAS R., Uraz S., et al.

IV. Ulusal Hepatoloji Kongresi ve Uluslararası Falk Workshop, İstanbul, Turkey, 14 - 16 June 2001, vol.1, pp.158, (Full Text) Sustainable Development

2001

2001

63. Kronik hepatit C infeksiyonu olan hastalarda oral liken planus prevalansı.

Engin B., Oğuz O., MERT A., ÖZARAS R., Uraz S., Tahan V., et al.

IV. Ulusal Hepatoloji Kongresi ve Uluslararası Falk Workshop, İstanbul, Turkey, 14 - 16 June 2001, vol.1, pp.129, (Full Text) Sustainable Development

2001

2001

64. Hemodiyaliz Hastalarında HCV Enfeksiyonunun Histopatolojik Değerlendirmesi

Yildirim B., MERT A., Özkan P., TABAK Ö. F., ÖZARAS R., ŞENTÜRK H.

IV. Ulusal Hepatoloji Kongresi ve Uluslararası Falk Workshop, İstanbul, Turkey, 13 - 16 June 2001, vol.1, pp.176, (Full Text)

2001

2001

65. The effect of interferon-? induction treatment with or without ribavirin in chronic hepatitis C: interim analysis.

ŞENTÜRK H., Ersöz G., ÖZARAS R., Kaymakoğlu S., Bozkaya H., MERT A., et al.

Digestive Disease Week, Atlanta, United States Of America, 20 - 23 May 2001, vol.1, pp.2884, (Full Text) Sustainable Development

2001

2001

66. Primary actinomycosis of the hand

MERT A., BİLİR M., Bahar H., Torun M., TABAK Ö. F., ÖZTÜRK R., et al.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.156, (Full Text)

2001

2001

67. Fever of unknown origin: a review of 130 patients.

MERT A., Çelik A. D., ÖZARAS R., TABAK Ö. F., ÖZTÜRK R., AKTUĞLU Y.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.153, (Full Text)

2001

2001

68. Primary tuberculosis of the parotid gland.

MERT A., ÖZARAS R., BİLİR M., Çiçek Y., TABAK Ö. F., Tahan V., et al.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.297, (Full Text) Sustainable Development

2001

2001

69. Infectious mononucleosis presenting with severe cholestatic liver disease in the elderly.

Tahan V., ÖZARAS R., MERT A., TABAK Ö. F., Çelik A. F., ÖZTÜRK R., et al.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.145, (Full Text)

2001

2001

70. Tuberculous lymphadenopathy: a review of 35 cases.

MERT A., TABAK Ö. F., ÖZARAS R., ÖZTÜRK R., Aki H., AKTUĞLU Y.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.297, (Full Text)

2001

2001

71. Primary tuberculosis cases presented with erythema nodosum.

MERT A., TABAK Ö. F., ÖZARAS R., ÖZTÜRK R., AKTUĞLU Y.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.297, (Full Text) Sustainable Development

2001

2001

72. Hyperpigmentation and severe thrombocytopenia due to pyrimethamine use

ÖZTÜRK R., Engin A., ÖZARAS R., MERT A., TABAK Ö. F., AKTUĞLU Y.

11th European Congress of Clinical Microbiology and Infectious Diseases, İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.1310, (Full Text)

2001

2001

73. Hepatic granulomas in chronic hepatitis C.

MERT A., ÖZARAS R., Tahan V., TABAK Ö. F., ÖZBAY G., AKTUĞLU Y.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.250, (Full Text) Sustainable Development

2001

2001

74. Toxic shock syndrome: a review of 22 cases.

MERT A., ÖZARAS R., TABAK Ö. F., ÖZTÜRK R., AKTUĞLU Y.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.99, (Full Text)

2001

2001

75. Acute viral hepatitis with severe hyperbilirubinemia and massive haemolysis in a patient with G-6-PD deficiency.

MERT A., ÖZARAS R., TABAK Ö. F., ÖZTÜRK R., Kanat M., AKTUĞLU Y.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.255, (Full Text) Sustainable Development

2001

2001

76. . Sarcoidosis developed after use of interferon for chronic hepatitis C

Tahan V., ÖZARAS R., MERT A., TABAK Ö. F., Çağatay T., ŞENTÜRK H.

11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.144, (Full Text) Sustainable Development

2001

2001

77. Primary tuberculosis of the parotid gland

MERT A., ÖZARAS R., BİLİR M., ÇİÇEK Y., TABAK Ö. F., Tahan V., et al.

11th European Congress of Clinical Microbiology and Infectious Diseases, İstanbul, Turkey, 1 - 04 April 2001, pp.1389, (Summary Text) Sustainable Development

2001

2001

78. Systemic nocardia infection in a patient with Behçet’s disease

Pamuk G. E., Pamuk Ö. N., TABAK Ö. F., MERT A., ÖZTÜRK R., Aktuğlu Y.

11th European Congress of Clinical Microbiology and Infectious Diseases, İstanbul, Turkey, 1 - 04 April 2001, pp.816, (Summary Text)

2000

2000

82. Prevalence of Serum Antibodies to Hepatitis C Virus is not increased in patients with sarcoidosis.

MERT A., BİLİR M., ÖZARAS R., TABAK Ö. F., Sipahi S., ÖZTÜRK R., et al.

10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.151 Sustainable Development

2000

2000

83. Aseptic meningitis and sensorineural hearing loss in adult-onset Still’s disease.

TABAK Ö. F., MERT A., ÖZTÜRK R., ÖZARAS R., AKTUĞLU Y.

10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.54, (Full Text)

2000

2000

84. Evaluation of HBsAg positive blood donors and results of long-term follow-up.

MERT A., TABAK Ö. F., ÖZARAS R., BİLİR M., ÖZTÜRK R., ŞENTÜRK H., et al.

10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.18, (Full Text)

2000

2000

85. Prevalence of serum antibodies to hepatitis C virus in patients with multiple sclerosis.

MERT A., Altıntaş A., BİLİR M., ÖZARAS R., TABAK Ö. F., ÖZTÜRK R., et al.

10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.151, (Full Text) Sustainable Development

2000

2000

86. The results of hepatitis B vaccination in sarcoidosis.

MERT A., BİLİR M., ÖZARAS R., TABAK Ö. F., Karayel T., ŞENTÜRK H.

10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.150, (Full Text) Sustainable Development

2000

2000

87. Infective endocarditis due to Corynebacterium striatum.

TABAK Ö. F., MERT A., ÖZTÜRK R., ÖZARAS R., AKTUĞLU Y.

10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.54, (Full Text)

2000

2000

88. Significance of infectious diseases in etiology of hepatic granulomas: Evaluation of 74 cases.

MERT A., BİLİR M., ÖZARAS R., Çetinkaya A., Tahan V., Yirmibeşcik S., et al.

10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.151 Sustainable Development

1999

1999

89. A spontaneous pneumothorax: A rare complication of during miliary tuberculosis.

BİLİR M., MERT A., TABAK Ö. F., ÖZTÜRK R., ÖZARAS R., AKTUĞLU Y.

European Respiratory Society Annual Congress, Madrid, Spain, 9 - 13 October 1999, vol.1, pp.312 Sustainable Development

1999

1999

90. Asemptomatik HBsAg Taşıyıcılarının Doğal Seyri

MERT A., TABAK Ö. F., ŞENTÜRK H., BİLİR M., ÖZARAS R., ÖZTÜRK R., et al.

III. Ulusal Hepatoloji Kongresi, İstanbul, Turkey, 27 - 29 May 1999, vol.1, pp.51, (Full Text)

1999

1999

91. The meaning of isolated anti-HBc positivity.

MERT A., ŞENTÜRK H., TABAK Ö. F., ÖZARAS R., Akdoğan M., Sander E., et al.

10th International Symposium on Viral Hepatitis and Liver Disease, Atlanta, United States Of America, 9 - 13 April 1999, vol.1, pp.21, (Full Text)

1998

1998

92. Anti-HCV ve HCV-RNA Pozitif, ALT Normal Olgularda Karaciğer Histolojisi

ÖZARAS R., MERT A., Tahan V., TABAK Ö. F., Akdoğan M., ŞENTÜRK H.

IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.65, (Full Text)

1998

1998

93. Sağlıklı HBsAg Taşıyıcılarında HBV-DNA Pozitiflik Oranı

ÖZARAS R., MERT A., ŞENTÜRK H., TABAK Ö. F., Tahan V., Akdoğan M., et al.

IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.30

1998

1998

94. Tedavisinde İnterferon Uygulanmasının Uzun Dönem Sonuçları

ÖZARAS R., TABAK Ö. F., MERT A., Tahan V., Akdoğan M., ŞENTÜRK H.

IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.72

1998

1998

95. Kronik Hepatit B’li Hastaların Çocuklarında Hepatit B Virüs Göstergeleri

Tahan V., MERT A., ÖZARAS R., TABAK Ö. F., Akdoğan M., ŞENTÜRK H.

IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.28 Sustainable Development

1998

1998

97. Kronik Hepatit C Havuzuna Hangi Yollarla Hasta Akmaktadır?

Tahan V., TABAK Ö. F., ÖZARAS R., MERT A., Akdoğan M., ŞENTÜRK H.

IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.71, (Full Text) Sustainable Development

1998

1998

98. Kronik Sağlıklı HBsAg Taşıyıcılarının Çeşitli Yönlerden Değerlendirilmesi

ÖZARAS R., MERT A., ŞENTÜRK H., TABAK Ö. F., Tahan V., Başaranoğlu M., et al.

IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.37, (Full Text)

1998

1998

99. Kronik Hepatit C’li Hastaların Çocuklarında Anti-HCV Pozitifliği

Tahan V., TABAK Ö. F., ÖZARAS R., MERT A., Akdoğan M., ŞENTÜRK H.

IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.66, (Full Text) Sustainable Development

1998

1998

100. Coinfection with hepatitis B and C in patients with chronic hepatitis: effects of interferon treatment

TABAK Ö. F., Tahan V., ÖZARAS R., MERT A., Yildirim B., Akdoğan M., et al.

European Association for the Study of the Liver, Postgraduate Course., İstanbul, Turkey, 26 - 27 June 1998, vol.1, pp.27, (Full Text) Sustainable Development

1998

1998

101. HCV-RNA positive blood donors: a histologic study.

MERT A., Yildirim B., Otağ F., BİLİR M., TABAK Ö. F., Akdoğan M., et al.

European Association for the Study of the Liver, Postgraduate Course., İstanbul, Turkey, 26 - 27 June 1998, vol.1, pp.26

1998

1998

102. The effect of diabetes mellitus on the treatment of chronic hepatitis C with interferon.

TABAK Ö. F., ÖZARAS R., Tahan V., MERT A., Akdoğan M., ŞENTÜRK H.

European Association for the Study of the Liver, Postgraduate Course., İstanbul, Turkey, 26 - 27 June 1998, vol.1, pp.28, (Full Text) Sustainable Development

1998

1998

103. Infectivity of chronic asymptomatic HBsAg carriers for their spouses.

MERT A., TABAK Ö. F., Tahan V., Yildirim B., ÖZARAS R., Otağ F., et al.

Recent Advances in the Diagnosis of Sexually Transmitted Diseases., İstanbul, Turkey, 10 - 13 June 1998, vol.1, pp.50, (Full Text)

1998

1998

104. Transmission of hepatitis C between spouses.

MERT A., TABAK Ö. F., ÖZARAS R., Yildirim B., Tahan V., Seyhan E., et al.

Recent Advances in the Diagnosis of Sexually Transmitted Diseases., İstanbul, Turkey, 10 - 13 June 1998, vol.1, pp.52, (Full Text) Sustainable Development

1998

1998

105. Should individuals with isolated anti-HBc be immunized against hepatits B virus

MERT A., BAŞARAN G., ÖZTÜRK R., TABAK Ö. F., ŞENTÜRK H., AKTUĞLU Y.

First World Congress on vaccines and immunization, İstanbul, Turkey, 26 - 30 April 1998, pp.0-17, (Full Text)

1997

1997

106. Tropical pyomyositis in a temperate climate

MERT A., KADIOĞLU P., TABAK Ö. F., Dumankar A., ÖZTÜRK R., Aktuğlu Y.

8th European Congress of Clinical Microbiology and Infectious Diseases, Lozan, Switzerland, 25 - 28 May 1997, pp.184-185, (Summary Text)

1996

1996

108. The resistance pattern of Acinetobacter species

ÖZTÜRK R., KÖKSAL ÇAKIRLAR F., Eroğlu C., Başaran G., Ayar E., Köksal S., et al.

10th Mediterranean Congress of Chemotherapy, Antalya, Turkey, 20 - 25 October 1996, pp.204, (Summary Text)

1996

1996

110. Anti-mycobacterial antibodies in Behçet’s syndrome.

MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.

VIIth International Conference on Behçet’s disease, Tunis, Tunisia, 10 - 11 October 1996, pp.25, (Summary Text)

1995

1995

111. Seronegatif bir Lyme hastalığı olgusu

Suna D., MERT A., BAVUNOĞLU I., ÖZTÜRK R., Tezcan V.

5.Ulusal İnfeksiyon Hastalıkları Kongresi,, İstanbul, Turkey, 4 - 06 September 1995, pp.66, (Summary Text)

1995

1995

112. . Seronegatif bir Lyme hastalığı olgusu

Suna D., MERT A., BAVUNOĞLU I., ÖZTÜRK R., Tezcan V.

5. Ulusal İnfeksiyon Hastalıkları Kongresi, İstanbul, Turkey, 4 - 06 September 1995, pp.15, (Full Text)

1995

1995

115. Alveolar hidatik hastalıkta (AHH) albendazol tedavisi

BAVUNOĞLU I., Şentürk H., MERT A., KORMAN M. U.

1. Ulusal Hepatoloji Kongresi, İstanbul, Turkey, 1 - 03 June 1995, pp.31, (Summary Text)

1995

1995

116. Rastlantısal ALT yüksekliği saptanan olgularda etyoloji

İlhan M., ŞENTÜRK H., MERT A., ÖZTÜRK R.

1.Ulusal Hepatoloji Kongresi, İstanbul, Turkey, 1 - 03 June 1995, pp.77, (Summary Text)

Books

2003

2003

1. Antibiyotikler ve antimikrobiyal profilaksi

ÖZTÜRK R., TABAK Ö. F., MERT A., AYGÜN G., Şahin N., Acicbe Ö., et al.

in: İç Hastalıkları, İliçin G, Biberğlu K, Süleymanlar G, Ünal S, Editor, Güneş Kitabevi, Ankara, pp.2863-2927, 2003


Citations

Total Citations (WOS): 766

h-index (WOS): 16